B. Riley Estimates OptimizeRx’s Q1 Earnings (NASDAQ:OPRX)
OptimizeRx Co. (NASDAQ:OPRX – Free Report) – Investment analysts at B. Riley issued their Q1 2025 earnings estimates for shares of OptimizeRx in a note issued to investors on Wednesday, March 12th. B. Riley analyst A. Schock forecasts that the company will earn ($0.34) per share for the quarter. B. Riley currently has a “Strong-Buy” […]
